ZAK Zürich pp 121-129 | Cite as

Toxikologische Aspekte der Inhalationsanästhetika

  • P. M. Lauven
  • H. Stoeckel
Conference paper
Part of the Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine book series (A+I, volume 188)

Zusammenfassung

Die nach wie vor eminente Bedeutung der Inhalationsnarkose und die seit 1967 in einer Vielzahl von Publikationen diskutierte toxische Potenz der Inhalationsanästhetika lassen eine kritische Beurteilung des Risikos notwendig erscheinen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ananth J (1975) Congenital malforation with psychopharmacoloc agents. Compr Psychiatry 16:437PubMedCrossRefGoogle Scholar
  2. 2.
    Askrog V, Harvald B (1970) Teratogen effect of inhalationsanaesthetika. Nord Med 83:498PubMedGoogle Scholar
  3. 3.
    Baden JM, Brinkenhoff M, Wharton RS (1976) Mutagenicity of volatile anesthetics: Halothane. Anesthesiology 45:311PubMedCrossRefGoogle Scholar
  4. 4.
    Baden JM, Kelley M, Wharton RS et al (1977) Mutagenicity of halogenated ether anesthetics. Anesthesiology 46:346PubMedCrossRefGoogle Scholar
  5. 5.
    Baden JM, Kelley M, Cheung A (1980) Lack of mutagens in urines of operating room personnel. Anesthesiology 53:195PubMedCrossRefGoogle Scholar
  6. 6.
    Basler A, Röhrborn G (1981) Lack of mutagenicity effects of halothane in mammals in vivo. Anesthesiology 55:143PubMedCrossRefGoogle Scholar
  7. 7.
    Blitt CD, Gandolf AJ, Soltis JJ et al (1981) Extrahepatic biotransformation of halothane and en-flurane. Anesth Analg 60:129PubMedGoogle Scholar
  8. 8.
    Bösterling B, Trudell JR, Hongk et al (1980) Formation of free radical intermediates during nitrous oxide metabolism by human intestinal contents. Biochem Pharmacol 29:3037PubMedCrossRefGoogle Scholar
  9. 9.
    Brown BR Jr (1982) Zum gegenwärtigen Stand der Hepatotoxizität von halogenierten Inhalations-anästhetika. In: Peter K, Jesch F (Hrsg) Inhalationsanästhesie heute und morgen. Springer, Berlin Heidelberg New York (Anästhesiologie und Intensivmedizin, Bd 149, S 13)Google Scholar
  10. 10.
    Bruce DL (1973) Murine fertility unaffected by traces of halothane. Anesthesiology 38:473PubMedCrossRefGoogle Scholar
  11. 11.
    Chase RE, Holaday DA, Fiserova-Bergerova V et al (1979) The biotransformation of ethrane in man. Anesthesiology 35:262CrossRefGoogle Scholar
  12. 12.
    Coate WB, Kapp RW, Lewis TR (1979) Chronic exposure to low concentrations of halothane-nitrous oxide: Reproductive and cytogenetic effects in the rat. Anesthesiology 50:310PubMedCrossRefGoogle Scholar
  13. 13.
    Cohen EN (1978) Toxicity of inhalation anaesthetic agents. Br J Anaesth 50:665PubMedCrossRefGoogle Scholar
  14. 14.
    Cohen EN, Bellville JW, Brown BW (1971) Anesthesia, pregnancy, and miscarriage: A study of operating room nurses and anesthetists. Anesthesiology 35:343PubMedCrossRefGoogle Scholar
  15. 15.
    Cohen EN, Brown BW, Bruce DL (1974) Occupational disease among operating room personnel: A national study. Report of an ad hoc committee on the effect of trace anesthetics on the health of operating room personnel (American Society of Anesthesiologists). Anesthesiology 41:321Google Scholar
  16. 16.
    Cohen EN, Brown BW, Wu M et al (1979) Anesthetic health hazards in the dental operatory. Anesthesiology 51:S254CrossRefGoogle Scholar
  17. 17.
    Cohen EN, Brown BW, Wu M et al (1980) Occupational disease in dentristy and chronic exposure to trace anesthetic gases. J Am Dent Assoc 101:21PubMedGoogle Scholar
  18. 18.
    Conklin KA, Lau SS (1979) Halothane does not inhibit synthesis of nucleic acids in tetrahymena pyriformis. Anesthesiology 51:508PubMedCrossRefGoogle Scholar
  19. 19.
    Conklin KA, Lau SS (1980) Enflurance effects on cell division and macromolecular synthesis in tetrahymena pyriformis: Comparison with halothane. Anesthesiology 53:287PubMedCrossRefGoogle Scholar
  20. 20.
    Corbett TH, Cornell RG, Endres JL et al (1974) Birth defects among children of nurse-anesthesists. Anesthesiology 41:341PubMedCrossRefGoogle Scholar
  21. 21.
    Van Dyke RA (1973) Biotransformation of volatile anaesthetics with special emphasis on the role of metabolism on the toxicity of anaesthetics. Can Anaesth Soc J 20:21PubMedCrossRefGoogle Scholar
  22. 22.
    Edmunds HN, Baden JM, Simmon VF (1979) Mutagenicity studies with volatile metabolites of halothane. Anesthesiology 51:424PubMedCrossRefGoogle Scholar
  23. 23.
    Ferstanding LL (1978) Trace concentrations of anesthetic gases: A critical review of their disease potential. Anesth Analg 57:328Google Scholar
  24. 24.
    Forth W (1983) Karzinogene, teratogene und mutagene Arzneimittelwirkungen. Bericht über das 5. Hauptthema des VII. Interdisziplinären Formus der Bundesärztekammer „Fortschritt und Fortbildung in der Medizin”, vom 12. bis zum 15. Januar 1983 in Köln. Dtsch Ärztebl 80:24Google Scholar
  25. 25.
    Green CJ, Monk SJ, Knight JF et al (1982) Chronic exposure of rats to enflurane 200 ppm: No evidence of toxicity or teratogenicity. Br J Anaesth 54:1097PubMedCrossRefGoogle Scholar
  26. 26.
    Halsey MJ, Green CJ, Monk S J et al (1981) Maternal and paternal chronic exposure to enflurane and halothane: Fetal and histological changes in the rat. Br J Anaesth 53:203PubMedCrossRefGoogle Scholar
  27. 27.
    Hill RM, Stern L (1979) Drugs in pregnancy: Effects on the fetus and newborn. Drugs 17:182PubMedCrossRefGoogle Scholar
  28. 28.
    Holaday DA, Rudolfsky S, Treuhaft PS (1970) Metabolic degradation of methoxyflurane in man. Anesthesiology 33:579CrossRefGoogle Scholar
  29. 29.
    Holaday DA, Fiserova-Bergerova V, Latto IP et al (1975) Resistance of isoflurane to biotransformation in man. Anesthesiology 43:325PubMedCrossRefGoogle Scholar
  30. 30.
    Kramers PG, Burn AG (1979) Mutagenicity studies with halothane in drosophila melanogaster. Anesthesiology 50:510PubMedCrossRefGoogle Scholar
  31. 31.
    Land PC, Owen EL, Linde HW (1979) Mouse sperm morphology following exposure to anesthetics during early spermatogenesis. Anesthesiology 51:S259CrossRefGoogle Scholar
  32. 32.
    Lane GA, Narwold ML, Tait AR et al (1979) Nitrous oxide is teratogenic: Xenon is not! Anesthesiology 51:S260CrossRefGoogle Scholar
  33. 33.
    Lauven PM, Stoeckel H (1982) Raumluftkonzentrationen der Inhalatiönsanäesthetika im Operationssaal. Der Einfluß von Schutzmaßnahmen. Anasth Intensivmed 23:1Google Scholar
  34. 34.
    Lenz W (1969) Der Zeitplan der menschlichen Organogenese als Maßstab für die Beurteilung terato-gener Wirkungen. Fortschr Med 87:520Google Scholar
  35. 35.
    Miller MS, Gandolfi AJ (1980) Enflurane biotransformation in humans. Life Sci 27:1465PubMedCrossRefGoogle Scholar
  36. 36.
    Nikki P, Pfaffli P, Ahlmann K, Ralli R (1972) Chronic exposure to anaesthetic gases in the operating theatre and recovery room. Ann Clin Res 4:266PubMedGoogle Scholar
  37. 37.
    Nunn JF, Lovis JD, Kimball KL (1971) Arrest of mitosis by halothane. Br J Anaesth 43:524PubMedCrossRefGoogle Scholar
  38. 38.
    Pope WD, Halsey MJ, Lansdown AB et al (1978) Fetotoxicity in rats following chronic exposure to halothane, nitrous oxide, or methoxyflurane. Anesthesiology 48:11PubMedCrossRefGoogle Scholar
  39. 39.
    Popova S, Virgieva T, Atanasova J et al (1979) Embryotoxicity and fertility study with halothane subanesthetic concentration in rats. Acta Anaesth Scand 23:505PubMedCrossRefGoogle Scholar
  40. 40.
    Rehder K, Forbes J, Alter H et al (1967) Halothane biotransformation in man: A quantitative study. Anesthesiology 28:711PubMedCrossRefGoogle Scholar
  41. 41.
    Spence AA, Cohen EN, Brown BW et al (1977) Occupational hazards for operating room-based physicians. JAMA 238:955PubMedCrossRefGoogle Scholar
  42. 42.
    Stoeckel HO, Lauven PM (1982) Exposition gegen Spurenkonzentrationen flüchtiger Anästhetika -gegenwärtige Beurteilung. In: Peter K, Jesch F (Hrsg) Inhalationsanästhesie heute und morgen. Springer, Berlin Heidelberg New York (Anästhesiologie und Intensivmedizin, Bd 149, S 21)Google Scholar
  43. 43.
    Trudeil JR, Hong K, O’Neil JR et al (1979) Metabolism of nitrous oxide by human and rat intestinal contents. Anesthesiology 51:S258CrossRefGoogle Scholar
  44. 44.
    Viera E, Cleaton-Jones P, Moyes D (1983) Effects of low intermittent concentrations of nitrous oxide on the developing rat fetus. Br J Anaesth 55:67CrossRefGoogle Scholar
  45. 45.
    Vogel F, Röhrborn G, Hansmann J (1974) Die Testung von Fremdstoffen auf Mutagenität. Arzneimittelforsch 24:1665PubMedGoogle Scholar
  46. 46.
    Waskell L (1979) Lack of mutagenicity of two possible metabolites of halothane. Anesthesiology 50:9PubMedCrossRefGoogle Scholar
  47. 47.
    Wharton RS, Mazze R (1979) Reproductive safety of enflurane in female mice. Anesthesiology 51: S261CrossRefGoogle Scholar
  48. 48.
    Wharton RS, Mazze RI, Baden JM et al (1978) Fertility, reproduction and postnatal survival in mice chronically exposed to halothane. Anesthesiology 48:167PubMedCrossRefGoogle Scholar
  49. 49.
    Wharton RS, Wilson A, Mazze R et al (1979) Fetal morphology in mice exposed to halothane. Anesthesiology 51:532PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • P. M. Lauven
  • H. Stoeckel

There are no affiliations available

Personalised recommendations